SMi is an innovative life science technology company revolutionising molecular science with its ground-breaking single-molecule imaging platform. This transformational technology provides unprecedented AI-powered super-resolution imaging to directly observe and quantify molecules and their intricate interactions with unparalleled accuracy and reliability. SMi’s multi-omic platform offers highly scalable throughput and flexibility, allowing the detection of a broad range of molecule types within a single test. This unique approach facilitates faster, better informed decisions that will drive the future of therapeutic and diagnostic development.

Established with a vision to bring its revolutionary platform to every laboratory bench, SMi delivers world-class results without the need for extensive training or specialized knowledge and will transform biomedical research and diagnostics through speed, quality and versatility.


Life Sciences

SMi Systems

SMi Systems' headquarters in Cambridge, United Kingdom

Pullman office focuses on scientific research and development, emphasizing leadership in innovative scientific inquiry.

Pullman

Andrew Thompson

Stephen Reeder

James Clark

This department provides strategic direction and oversight for the organization.

Executive Leadership

This department focuses on the development and optimization of assay methods and protocols for various research and diagnostic applications.

Assay Development

This department manages financial operations and oversees project implementation to ensure organizational efficiency.

Finance and Projects

This department focuses on conducting experiments and analyses to advance scientific knowledge and innovations.

SMi Systems

Org chart

Teams

Executive Leadership

Assay Development

Finance and Projects

Scientific Research

Offices

SMi Systems

Org chart

Teams

Executive Leadership

Assay Development

Finance and Projects

Scientific Research

Offices

Related companies